+10 or trisomy 10 (solely)

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home Genes Leukemias Solid Tumours Cancer-Prone Deep Insight Case Reports Journals Portal Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

+10 or trisomy 10 (solely)

Clinics and Pathology

Disease Acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), Acute Biphenotypic Leukemia, and myelodysplastic syndromes (MDS).

Note Classification : Approximately 33 cases with isolated Trisomy 10 have been described. Over two-thirds of cases associated with this cytogenetic abnormality are AML-M0, M1, or M2; M2 is the most common AML variant in the FAB classification (one-third of cases). Trisomy 10 has been, however, described in all of the FAB variants except . Over half of the AML cases have been associated with CD7 expression. Twenty-one cases of AML (including one of our own cases) have been described in the literature. One case each of biphenotypic acute leukemia and eosinophilic leukemia with trisomy 10 have been described. Two cases (including one of our own cases) of high grade MDS (i.e. refractory anemia with excess blasts-2 (RAEB-2)) have been associated with isolated trisomy 10. When specified, most cases of ALL were of the Pre-B type. There have been eight cases of ALL with +10 as the sole abnormality.

Phenotype / cell stem origin ALL cases are mostly pre B ALL; AML cases are M0, M1 or M2 AML, with, in most cases, a CD7+, CD33+ phenotype.

Epidemiology The incidence of isolated trisomy 10 is less than 1% in acute leukemia. About sixty percent of the AML cases have been in males while the ALL cases have had a near equal male to female ratio. About half of the AML cases have been in patients of Oriental descent. AML cases have ranged in age from two to eighty years of age with a median age of fifty-four years. ALL cases with this cytogenetic abnormality are not strictly seen in the pediatric age range. Three cases (including one of our own cases) have been seen in the adult population.

Clinics in ANLL cases: WBC: 20 X 10⁹/l; high blast percentage, low haemoglobin.

Prognosis About half of the AML cases and two-thirds of the ALL cases have had at least a one year survival after diagnosis. The average survival for AML cases has been 26 months while the ALL cases had a 19 month average survival.

Genetics

genes involved are unknown

Cytogenetics

Result of the chromosomal anomaly

External links

Other database +10 or trisomy 10 (solely) Mitelman database (CGAP - NCBI)

Other database	+10 or trisomy 10 (solely)	Mitelman database (CGAP - NCBI)

To be noted

Bibliography

Agar culture and chromosome analysis of eosinophilic leukaemia.

Goldman JM, Najfeld V, Th'ng KH

Journal of clinical pathology. 1975 ; 28 (12) : 956-961.

PMID 1206119

The relationship between growth in agar, karyotype and prognosis in acute leukaemia.

Gustavsson A, Mitelman F, Olofsson T, Olsson I

Scandinavian journal of haematology. 1984 ; 32 (4) : 351-363.

PMID 6585926

A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7--morphologic, cytochemical, immunocytochemical and T cell receptor gene analysis on 13 patients.

Tien HF, Wang CH, Su IJ, Liu FS, Wu HS, Chen YC, Lin KH, Lee SC, Shen MC

Leukemia research. 1990 ; 14 (6) : 515-523.

PMID 1695699

Chromosomenaberrationen bei akuten Leukamien im Kindesalter: Analyse von 1009 Patienten.

Lampert F, Harbott J, and Ritterbach J

Kliniknahe Grundlagenforschung. 1991 ; 203 (numero 4) : 311-318.

Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents.

Cuneo A, Fagioli F, Pazzi I, Tallarico A, Previati R, Piva N, Carli MG, Balboni M, Castoldi G

Leukemia research. 1992 ; 16 (8) : 789-796.

PMID 1528067

Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.

Fagioli F, Cuneo A, Piva N, Carli MG, Previati R, Balboni M, Tomasi P, Cariani D, Scapoli G, Castoldi G

Cancer. 1992 ; 70 (1) : 77-85.

PMID 1606550

Hyperdiploid (47-50) acute lymphoblastic leukemia in children.

Raimondi SC, Roberson PK, Pui CH, Behm FG, Rivera GK

Blood. 1992 ; 79 (12) : 3245-3252.

PMID 1596566

In situ hybridization to interphase nuclei in acute leukemia.

Romana SP, Cherif D, Le Coniat M, Derrˆ© J, Flexor MA, Berger R

Genes, chromosomes & cancer. 1993 ; 8 (2) : 98-103.

PMID 7504523

Clonal analysis of progenitor cells by interphase cytogenetics in patients with acute myeloid leukemia and myelodysplasia.

Van Der Lely N, Poddighe P, Wessels J, Hopman A, Geurts van Kessel A, De Witte T

Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1995 ; 9 (7) : 1167-1172.

PMID 7630192

Trisomy 10: age and leukemic lineage associations.

Morgan R, Chen Z, Stone JF, Cohen J, Gustafson E, Jolly PC, Sandberg AA

Cancer genetics and cytogenetics. 1996 ; 89 (2) : 173-174.

PMID 8697428

Trisomy 10 in acute myeloid leukemia.

Ohyashiki K, Kodama A, Nakamura H, Wakasugi K, Uchida H, Shirota T, Ito H, Toyama K

Cancer genetics and cytogenetics. 1996 ; 89 (2) : 114-117.

PMID 8697414

Trisomy 10 in leukemia.

Estalilla O, Rintels P, Mark HF

Cancer genetics and cytogenetics. 1998 ; 101 (1) : 68-71.

PMID 9460504

Trisomy 10 in acute myeloid leukemia: report of a new case.

Luˆ±o E, Payer AR, Luengo JR, Del Castillo TB, Garcia VP

Cancer genetics and cytogenetics. 1998 ; 100 (1) : 84-87.

PMID 9406587

Trisomy 10 survival: a literature review and presentation of seven new cases.

Pedersen B, Andersen CL, Sˆ½gaard MM, Nˆ½rgaard JM, Koch J, Krejci K, Brandsborg M, Clausen N

Cancer genetics and cytogenetics. 1998 ; 103 (2) : 130-132.

PMID 9614911

Are cells with trisomy 10 always malignant in hematopoietic disorders?

Berger R, Busson-Le Coniat M

Annales de genetique. 1999 ; 42 (1) : 5-10.

PMID 10214501

Trisomy 10 as a sole chromosomal abnormality in AML-M2.

Estalilla O, Rintels P, Mark HF

Cancer genetics and cytogenetics. 1999 ; 108 (2) : page 175.

PMID 9973950

Trisomy 10 in acute myeloid leukemia: three new cases.

Llewellyn IE, Morris CM, Stanworth S, Heaton DC, Spearing RL

Cancer genetics and cytogenetics. 2000 ; 118 (2) : 148-150.

PMID 10748296

Trisomy 10 in acute myeloid leukemia: revisited.

Ma SK, Wan TS, Chan LC, Au WY

Cancer genetics and cytogenetics. 1999 ; 109 (1) : 88-89.

PMID 9973969

Trisomy 10 in adult pre-B-cell leukemia.

Okamura A, Yamaguchi A, Shimizu S, Kadowaki S, Chihara K, Matsui T, Fujimoto T, Kanki K, Fujio K

American journal of hematology. 1999 ; 61 (1) : page 83.

PMID 10331517

Trisomy 10 in a child with acute nonlymphocytic leukemia followed by relapse with a different clone.

Sakai Y, Nakayama H, Matsuzaki A, Nagatoshi Y, Suminoe A, Honda K, Inamitsu T, Ohga S, Hara T

Cancer genetics and cytogenetics. 1999 ; 115 (1) : 47-51.

PMID 10565299

Trisomy 10 as the sole abnormality in biphenotypic leukemia.

Inoue T, Fujiyama Y, Kitamura S, Andoh A, Hodohara K, Bamba T

Leukemia & lymphoma. 2000 ; 39 (3-4) : 405-409.

PMID 11342322

Trisomy 10 in acute myeloid leukemia. Three additional cases from the database of the Japan Adult Leukemia Study Group (JALSG) AML-92 and AML-95.

Suzuki A, Kimura Y, Ohyashiki K, Kitano K, Kageyama S, Kasai M, Miyawaki S, Ohno R

Cancer genetics and cytogenetics. 2000 ; 120 (2) : 141-143.

PMID 10942805

Trisomy 10 and acute myeloid leukemia.

Czepulkowski B, Powell AR, Pagliuca A, Mufti GJ

Cancer genetics and cytogenetics. 2002 ; 134 (1) : 81-83.

PMID 11996802

Contributor(s)

Written 08-1998 Jean-Loup Huret

-

Updated 05-2006 Zachary T Lewis, Patrick P Koty, Mark J PettenatiUTHOR_AFFILIATION Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

Department of Pediatrics, Section on Medical Genetics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA

Citation

This paper should be referenced as such :
Huret JL . +10 or trisomy 10 (solely). Atlas Genet Cytogenet Oncol Haematol. August 1998 .
URL : http://AtlasGeneticsOncology.org/Genes/tri10ID1063.html

Lewis ZT, Koty PP, Pettenati MJ . +10 or trisomy 10 (solely). Atlas Genet Cytogenet Oncol Haematol. May 2006 .
URL : http://AtlasGeneticsOncology.org/Genes/tri10ID1063.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Sep 5 17:10:37 2008

Home Genes Leukemias Solid Tumours Cancer-Prone Deep Insight Case Reports Journals Portal Teaching

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.

Disease	Acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), Acute Biphenotypic Leukemia, and myelodysplastic syndromes (MDS).
Note	Classification : Approximately 33 cases with isolated Trisomy 10 have been described. Over two-thirds of cases associated with this cytogenetic abnormality are AML-M0, M1, or M2; M2 is the most common AML variant in the FAB classification (one-third of cases). Trisomy 10 has been, however, described in all of the FAB variants except . Over half of the AML cases have been associated with CD7 expression. Twenty-one cases of AML (including one of our own cases) have been described in the literature. One case each of biphenotypic acute leukemia and eosinophilic leukemia with trisomy 10 have been described. Two cases (including one of our own cases) of high grade MDS (i.e. refractory anemia with excess blasts-2 (RAEB-2)) have been associated with isolated trisomy 10. When specified, most cases of ALL were of the Pre-B type. There have been eight cases of ALL with +10 as the sole abnormality.
Phenotype / cell stem origin	ALL cases are mostly pre B ALL; AML cases are M0, M1 or M2 AML, with, in most cases, a CD7+, CD33+ phenotype.
Epidemiology	The incidence of isolated trisomy 10 is less than 1% in acute leukemia. About sixty percent of the AML cases have been in males while the ALL cases have had a near equal male to female ratio. About half of the AML cases have been in patients of Oriental descent. AML cases have ranged in age from two to eighty years of age with a median age of fifty-four years. ALL cases with this cytogenetic abnormality are not strictly seen in the pediatric age range. Three cases (including one of our own cases) have been seen in the adult population.
Clinics	in ANLL cases: WBC: 20 X 10⁹/l; high blast percentage, low haemoglobin.
Prognosis	About half of the AML cases and two-thirds of the ALL cases have had at least a one year survival after diagnosis. The average survival for AML cases has been 26 months while the ALL cases had a 19 month average survival.

Written	08-1998	Jean-Loup Huret
		-
Updated	05-2006	Zachary T Lewis, Patrick P Koty, Mark J PettenatiUTHOR_AFFILIATION Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
		Department of Pediatrics, Section on Medical Genetics, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA